| 0.255 -0.013 (-4.85%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.61 | 1-year : | 0.84 |
| Resists | First : | 0.52 | Second : | 0.72 |
| Pivot price | 0.31 |
|||
| Supports | First : | 0.21 | Second : | 0.18 |
| MAs | MA(5) : | 0.27 |
MA(20) : | 0.32 |
| MA(100) : | 0.26  |
MA(250) : | 0.92 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 21.6 |
D(3) : | 24.6 |
| RSI | RSI(14): 42.1 |
|||
| 52-week | High : | 3.28 | Low : | 0.18 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ YTEN ] has closed above bottom band by 19.3%. Bollinger Bands are 58.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 20 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.28 - 0.28 | 0.28 - 0.28 |
| Low: | 0.25 - 0.25 | 0.25 - 0.25 |
| Close: | 0.25 - 0.26 | 0.26 - 0.26 |
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Fri, 05 Apr 2024
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript - Yahoo Finance
Mon, 01 Apr 2024
Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript - Seeking Alpha
Thu, 28 Mar 2024
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on ... - GlobeNewswire
Thu, 21 Mar 2024
Why Is Yield10 (YTEN) Stock Up 117% Today? - InvestorPlace
Thu, 21 Mar 2024
USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the ... - Yahoo Finance
Thu, 21 Mar 2024
Is Yield10 Bioscience Inc (YTEN) a Bad Choice in Agricultural Inputs Thursday? - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Agricultural Inputs
|
|
| Shares Out | -5 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.54e+007 (%) |
| Held by Institutions | 1.421e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.83 |
| Profit Margin | 0 % |
| Operating Margin | -24 % |
| Return on Assets (ttm) | 28.3 % |
| Return on Equity (ttm) | -150.3 % |
| Qtrly Rev. Growth | 508 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -250.51 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1.413e+007 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -0.15 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0 |
| Dividend | 940870 |
| Forward Dividend | 290520 |
| Dividend Yield | 368969000% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|